Dr Reddy's Laboratories Ltd (RDY)
69.54
-0.07
(-0.10%)
USD |
NYSE |
May 24, 10:07
Dr Reddy's Laboratories Revenue (Annual): 3.372B for March 31, 2024
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.372B |
| March 31, 2023 | 3.067B |
| March 31, 2022 | 2.878B |
| March 31, 2021 | 2.551B |
| March 31, 2020 | 2.459B |
| March 31, 2019 | 2.199B |
| March 31, 2018 | 2.203B |
| March 31, 2017 | 2.100B |
| March 31, 2016 | 2.365B |
| March 31, 2015 | 2.424B |
| March 31, 2014 | 2.193B |
| March 31, 2013 | 2.139B |
| Date | Value |
|---|---|
| March 31, 2012 | 2.027B |
| March 31, 2011 | 1.641B |
| March 31, 2010 | 1.484B |
| March 31, 2009 | 1.513B |
| March 31, 2008 | 1.248B |
| March 31, 2007 | 1.448B |
| March 31, 2006 | 551.38M |
| March 31, 2005 | 435.94M |
| March 31, 2004 | 438.20M |
| March 31, 2003 | 372.07M |
| March 31, 2002 | 347.63M |
| March 31, 2001 | 239.16M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
2.459B
Minimum
2020
3.372B
Maximum
2024
2.865B
Average
2.878B
Median
2022
Revenue (Annual) Benchmarks
| Concord Medical Services Holdings Ltd | 75.97M |
| ASLAN Pharmaceuticals Ltd | 12.00M |
| Zai Lab Ltd | 266.72M |
| ICICI Bank Ltd | 19.56B |
| SS Innovations International Inc | -- |